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Introduction
The recent progress in stem cell biology has created new
approaches for their study as well as their application to the
treatment of human diseases [1–3]. The success of stem-
cell based technologies in the clinical setting [4, 5] has
emphasized the need to improve the standards of quality for
all phases of cell therapy, particularly the development of
culture methods that circumvent products of animal origin
since these might provoke infections or immune rejection
following transplantation in patients. Indeed, since Martin
et al. (2005) [6] demonstrated that hESC cultured with
animal or serum products retained non-human sialic acid
which was immunogenic when transplanted in humans, the
establishment of animal-free conditions to support the
maintenance and differentiation of human stem cells has
been a major goal of the field of regenerative medicine [7].
Thus, chemically-defined culture systems that are devoid of
non-human substances will greatly facilitate the use of stem
cells in regenerative strategies.
The concept of a niche is crucial for the organization of
stem cells. A niche is consider as a subset of tissue cells and
extracellular substrates (matrix and soluble factors) that can
support stem cells and control their self-renewal in vivo [8].
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DOI 10.1007/s12015-011-9270-6Extracellular matrices help to structure niches spatially and
modulate the concentration of adhesive and signalling
molecules locally. The ECM is a molecular complex that
contains collagens and other glycoproteins, hyaluronic acid,
proteoglycans, glycosaminoglycans (GAGs), and elastins.
Additionally, the ECM harbours growth factors or cyto-
kines to protect against degradation [9]. ECM components
are responsible for adhesion during the majority of cell
interactions and are implicated in the maintenance of
embryonic induction during development as well as stem
cell differentiation in vitro [10]. Thus, local changes in
ECM can dramatically modulate the proliferation and
migration of stem cells and may participate in the
specification of lineages.
hESC have provided invaluable tools for gaining insight
into the developmental origins of human tissues. However, to
realize the full biological and clinical potential of hESC,
certain problems related with the routine culture of these cells
must be solved. Mouse embryonic fibroblasts (MEFs) and
murine derivatives such as Matrigel are widely used in the
maintenance and differentiation of hESC. Recently, consider-
able effort has been dedicated to the elimination of animal-
derived reagents from the culture of hESC and in parallel, to
the control of cell growth parameters by avoiding human
feeder cells. For example, in 2006 Ludwig et al. reported the
use of conditioned media and high doses of FGF to maintain
the undifferentiated state in hESC cultured on plastic, but some
abnormalities were detected at passage 20 under these
conditions [11, 12]. The use of human feeders complicates
the growth and molecular analysis of both pluripotency and
differentiation since experimental data may reflect the
combined effects of hESC and feeder cells in the culture.
Given these considerations, the use of an ECM of human or
synthetic origin would provide many advantages. Indeed,
t h e r eh a v eb e e na t t e m p t s[ 13, 14] to produce such a tool but
the results have not been satisfactory because the products
were unable to maintain hESC in the undifferentiated state
over time. Matrix proteins have been used as coating for in
vitro cultures of human stem cells but they have usually been
applied as undefined protein mixtures [11]o fa n i m a lo r i g i n
[15] with undefined media [13], serum [16]o ras y n t h e t i c
mixture [17, 18]. However, most of these human biological
reagents are expensive to manufacture and thus, are cost-
prohibitive for many laboratories.
Decellularization procedures have been used traditionally
to isolate ECM from cells in culture, tissues or organs [19].
The goal of decellularization protocols is to efficiently
remove cellular and nuclear material while minimizing any
adverse effect on the composition, biological activity and
mechanical and structural integrity of the remaining
ECM [20, 21]. Decellularized human scaffolds have
facilitated the remodelling of various tissues in both
animal models and humans [4, 22]. However, any
biochemical procedure employed to remove cells may
also alter the native three-dimensional architecture of the
ECM and thus, a balance must be achieved between
chemical and physical treatments during the decellulariza-
tion process [4, 5, 23].
Given the potential importance of hESC in translational
research and regenerative medicine, the aim of the present
study was to develop a simple, efficient protocol for the
production of a human ECM that is both safe and
economical. Here we report that hypotonic lysis of human
foreskin fibroblasts (HFF) generates a human ECM that
retains protein components which are essential for attach-
ment and cell-cell interaction. This hffECM was capable of
maintaining the pluripotency of hESC and supporting their
differentiation when used with the appropriate medium.
Therefore, our results reveal hffECM as a novel tool which
may facilitate the clinical application of hESC-based
technologies.
Results
Optimisation of Conditions for the Generation
of a Functional ECM from Human Foreskin Fibroblasts
To obtain a human ECM which would support the
maintenance of undifferentiated stem cells, we initially
designed a protocol using RIPA buffer to extract ECM
from cultured HFF [24]. However, to optimise this
matrix for clinical applications, we contemplated the use
of a buffer to induce osmotic shock, thereby circum-
venting the use of detergents to lyse attached fibroblasts.
Thus, HFF (passage 11–18) were grown to confluence
and then inactivated with mitomycin C. Subsequently,
these cultures were lysed with a Tris-Buffer which
triggered osmotic shock. Incubation with this buffer
caused the cells to swell and detach from the plate. This
process was facilitated by six washes with PBS to remove
broken cells and debris (see Fig. 1 for the details).
Structural Characterization of hffECM
To assess whether ECM proteins were retained after the cell
lysis procedure, plates were examined by various microscopy
techniques. Control plates of intact HFF (Fig. 2 a1–a4)a n d
experimental cell-free plates (Fig. 2 a5–a8) were fixed and
processed for ultrastructural analysis using transmission
electron microscopy (TEM). The optimal length of cell
culture for the obtention of hffECM was determined by
assessing HFF which were cultured for either two, nine or
12 days prior to lysis (Fig. 2a). Following treatment with
lysis buffer, intact fibroblasts were not observed on any of
t h ep l a t e sa sv e r i f i e db yD A P Is t a i n i n go fn u c l e i( F i g .2
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preserved based on microscopic analysis (Fig. 2 a5). The
hffECM obtained from HFF cultured for only 2 days had a
low content of structural proteins (Fig. 2 a-6), as evidenced
by the loose lattice of fibers, suggesting that two days of
culture is insufficient for preparation of a quality hffECM.
After 12 days of culture, protein fibers displayed signs of
degradation (Fig. 2 a-8). Thus, the quantity and architecture
of the ECM from HFF cultured for 7–9d a y s( s e eF i g .2 a-7)
suggested that this amount of time might provide the best
quality cell-free matrix. The presence of characteristic ECM
adhesion proteins before and after the treatment was
confirmed by immunostaining (Fig. 2b) using antibodies
against fibronectin (Fig. 2 b1,2), collagen (Fig. 2 b3,4)a n d
laminin (Fig. 2 b5,6). Collectively, the results of these
studies demonstrate that the hffECM retains a structure
similar to the ECM of intact HFF, suggesting that the lysis
conditions do not damage significantly the organization of
the matrix.
Detergent-Free Cell Lysis Preserves the Structure
and Composition of the hffECM
To characterize the composition of the matrix obtained from
the human fibroblasts, we eluted the hffECM from culture
plates and performed a proteomic study. A total of 220
proteins were identified with a false discovery rates (FDRs)
below 5% (Table 1, Supplementary information). To
evaluate the origin of the proteins, the enrichment of the
cellular compartment terms of gene ontology was analyzed
using Babelomics [25, 26] (Supplementary Fig. 1). At level
4, only the terms extracellular matrix (GO:0031012) and
cell surface components (GO:0009986) were significantly
enriched (p<0.01). The function of the proteins included in
these terms are highly related as indicated by the network
created by STRING analysis (Fig. 3a). These results
demonstrate that many of the proteins responsible for the
interaction between the cell surface and the ECM network
are present in the hffECM. Although laminin was detected
in the intact hffECM by immunocytochemistry, we were
not able to identify it by mass spectrometry in samples of
eluted hffECM. The most probable explanation for this
discrepancy is the low recovery of laminin from the culture
dishes due to its low solubility once assembled in the ECM.
To obtain further information regarding the functional
aspects of the hffECM proteins, the enrichment of Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways
was also analyzed. Of the ten pathways significantly
enriched (p<0.01, Supplementary information), three are
related with focal adhesions and the cytoskeleton and play
important roles in cell proliferation, differentiation, and
survival. A part of the focal adhesion pathway is the
Fig. 1 Experimental design for the obtention, analysis and applica-
tions of hffECM. Human foreskin fibroblasts (passage 11 to 18) were
cultured during 7–9 days before inactivation with mitomycin C. At
this stage, cultures were treated overnight at 4°C with lysis buffer to
remove cells and the resulting hffECM was subjected to one of the
following procedures: (a-1) Assessment of hECM protein integrity
and characterization. Electron microscopy analysis was performed to
evaluate the integrity and composition of hECM after the treatment
and to establish the optimal period for obtention (see Fig. 2a).
Immunocytochemistry (ICQ) was used to confirm visually the
presence of characteristic ECM components (see Fig. 2b). (a-2)
Identification of ECM proteins by proteomic analysis (Fig. 3). (a-3)
Application of hffECM to biological processes. To test the functional
capacity of the hffECM, we designed and performed different
experiments related with pluripotency (Fig. 4a-e) and differentiation
of hESC towards the three germ layers (Fig. 5 and Supplementary
Fig. 1a-f) as well as the migration of adults cells (Fig. 6 a-c and
Supplementary videos 1–3)
172 Stem Cell Rev and Rep (2012) 8:170–183extracellular matrix-receptor interaction pathway, which
mediates the interactions with integrins and proteoglycans.
As indicated in Fig. 3b, most of the extracellular partners of
the pathway were detected in hffECM. Collectively, the
Fig. 2 Evaluation of the structural integrity of the hffECM. a
Ultrastructural analysis of the efficiency of extraction protocol using
transmission electron microscopy. Plates of lysed cultures and their
respective controls with intact foreskin fibroblasts were fixed and
processed for transmission electron microscopy ultrastructural analy-
sis. To determine the optimal length of culture for production of
hffECM, HFFs were maintained for the indicated times and then
subjected to hypotonic lysis. (a1, a5) Semi-thin sections were
prepared from control and lysed cultures and were stained with
toluidine blue. (a2-a4) Representative TEM images of intact HFF
control cultures at the indicated time-points. (a6-a8) Representative
TEM images of lysed culture plates at the indicated time-points. Scale
bars,100μm( a-1 and a-5), 2 μm (a-3 and a-4),1μm (a-2,a-7 and a-8).
b Immunocytochemical analysis of structural proteins in hffECM.
Control cultures of intact HFF or lysed plates were immunostained with
antibodies against fibronectin (b-1, b-2), collagen type I (b-3, b-4) and
laminin (b-5, b-6). Note that fibronectin, collagen type I and laminin
were retained on plates after the treatment with lysis buffer. Cell
nuclei as detected by DAPI were absent in lysed cultures. All
images were captured at 63X magnification using a Leica confocal
microscope, with the appropriate lasers to excite the secondary
antibodies (Alexa, 488 nm) and 405 nm for DAPI
Stem Cell Rev and Rep (2012) 8:170–183 173Fig. 3 Identification of protein
components of the hffECM.
After removal of HFF by lysis,
the remaining hffECM was
eluted from culture plates and
subjected to proteomic analysis.
a STRING analysis of the
proteins contained in the cellular
component terms of gene
ontology that are significantly
enriched in the hffECM
samples. The two principal
clusters correspond mainly to
proteins of the extracellular
matrix (blue) or cellular surface
components (green). Note that
the components form tight
networks with several inter-
cluster connections. b Protein
components of the human ECM-
receptor interaction pathway of
the KEGG database. The
proteins of the hffECM identi-
fied by mass spectrometry are in
indicated in red. Laminin, in
blue, was detected by immnu-
nocytochemical analysis of the
hffECM. Most of the extracel-
lular matrix partners of the
pathway have been identified
174 Stem Cell Rev and Rep (2012) 8:170–183results of the proteomics analysis demonstrate that the
procedure we have developed for preparation of hffECM
retains most of the key components necessary for cell
attachment and regulation of proliferation and differentia-
tion. Regarding the other enriched pathways, some may
reflect contaminants due to non-specific binding (e.g.,
ribosomal proteins and histones) whereas others may have
been identified because they are anchored to the plasma
membrane, cytoskeleton, and/or ECM. Interestingly, some
glycolytic pathways were enriched (pathways hsa00620
and hsa00010). Although their origin is not clear, it is
noteworthy that they are components of the anaerobic
glycolysis pathway and one might speculate that they may
be located at the extracellular space to provide energy
locally to the ATP-dependent processes that may occur in
this vicinity.
hffECM Maintains Pluripotency of hESC
Colonies of H9 (passage 31), maintained on HFF, were cut
mechanically and distributed equally into 4 experimental
groups. One group was again plated on HFF and
maintained during the assay using traditional conditions
for hESC culture. The other 3 groups of hESC colonies,
were seeded onto hffECM-coated plates, using either
TESR1 feeder-conditioned medium, feeder-conditioned
medium 1, or the traditional KSR medium + bFGF as a
control. Subsequently, cultures were passaged mecanically
every 5–6 days. Colonies seeded on human hffECM and
maintained with KSR or conditioned medium 1 began to
display a morphology consistent with spontaneous differ-
entiation after 2 to 5 passages. In contrast, colonies plated
on hffECM with TERS1 conditioned media retained the
morphology of undifferentiated colonies with defined
borders and a compact sphere, similar to hESC maintained
on feeders (Fig. 4a, b). To ensure that colonies were indeed
growing on the hffECM, cultures were stained with anti-
fibronectin (Fig. 4b-3). Detection of this ECM component
under and around the colonies suggests that the cells were
plated on hffECM and not the plastic of the culture plate.
DAPI was used to counter-stain the nuclei of cultured cells.
In the image a-3 of Fig. 4, blue nuclei were observed in
hESC colonies and feeder cells. However, in cultures
maintained on hffECM, DAPI staining was detected
exclusively in the colonies but not around them, reinforcing
the observation that intact human feeder cells were
eliminated during preparation of the hffECM. (For more
details, see Supplementary Fig. 2)
After 21 passages on hffECM, the H9 colonies
displayed a normal female kariotype of 46 XX
(Fig. 4c). Telomerase activity was similar between H9
cells at the onset of the experiment (passage 31) and those
maintained for 21 additional passages (total of 52
passages) on either hffECM or HFF (Fig. 4d). Addition-
ally, the hESC maintained on hffECM continued to
express markers of pluripotency at levels equivalent or
superior to those detected in hESC grown on feeder layers
(Fig. 4e). These data suggest that hffECM supports H9
colonies in the undifferentiated state. Similar observations
were made with the H1 cell line.
hffECM Supports Differentiation of hESC
To facilitate clinical applications, ECM that meets the
requirements of an animal-free product should also
support differentiation of hESC. To test spontaneous
differentiation, H9 colonies were allowed to overgrow
on hffECM under conditions of bFGF deprivation for at
least 2 weeks. Subsequent analysis by immunostaining
revealed that the cultures had differentiated to ectoderm
(Tuj1 positive cells) and mesoderm (cardiac actin)
(Supplementary Fig. 3 a,b).
To determine the compatibility of the hffECM with the
differentiation of hESC by chemically-defined protocols,
H9 colonies were cultured on this matrix under conditions
known to generate human adipocytes [27]. After 15 days in
this differentiation medium (Fig. 5a), the cultures were
analysed for lipid accumulation and markers of adipose
tissue. We detected the presence of many Oil red O-stained
lipid droplets in the cytoplasm of the cells on hffECM
(Fig. 5b). Detailed ultrastructure analysis of differentiated
cells using TEM revealed that their morphology was
compatible with mature adipocytes (Fig. 5c), suggesting
the functional capacity of this matrix to promote directed
differentiation. To confirm that these cells were indeed
adipocytes, the expression of adipose-specific genes was
examined by RT-PCR using human adipose tissue as a
positive control. Consistent with the presence of lipid
droplets, aP2 and PPARγ, transcriptional factors which are
required for adipogenesis, were up-regulated significantly
after 3 days in differentiation medium, demonstrating that the
hffECM promotes differentiation of hESC under defined
conditions. Consistent with this, when H9 grown on hffECM
were subjected to a published protocol for the step-wise
induction of endoderm [28], markers of definitive endoderm
were observed after 3 weeks (Supplementary Fig. 3 c-f).
Additionally, an earlier version of our hffECM was used
successfully for differentiating H9 to endothelial precursors
and mature endothelial cells [29].
hffECM Supports Cell Migration in 3-D
The removal of adhesion proteins and GAGs from the ECM
would be expected to slow cell migration on the coated
Stem Cell Rev and Rep (2012) 8:170–183 175surface and reduce the bioactivity of the surface itself.
Disruption of the collagen network changes the mechanical
properties and collagen fiber kinetics of the scaffold, which
can alter the environment to which cells are exposed [30].
Given these considerations, we compared the capacity of our
hffECM to support cell migration events with standard
materials such as Matrigel and plastic. A migration assay
was performed using the human brain tumor cell line U87,
routinely used for migration studies [31], which was plated
on the three different supports. Subsequently, we recorded
the trajectory and direction changes of at least 20 cells
migrating on each of the supports. Cells plated on plastic
Fig. 4 Analysis of pluripotency in cultures of H9 maintained on
hffECM. Morphology of H9 colonies maintained for 21 passages on
either human foreskin fibroblasts a or hffECM b. Immunodetection of
the undifferentiated marker Tra1-60 in H9 colonies maintained during
21 passages on foreskin fibroblasts (a2), or after 21 passages on
hffECM (b2). Nuclei were stained with DAPI (blue) and Alexa 488
secondary antibodies (green) were used to detect anti-Tra1-60. All the
images were captured at 10X magnification in a Zeiss Axiovert 200 M
fluorescence microscope. c Kariotype analysis. After 31 passages on
hffECM, hESC cells conserve normal 46XX kariotype. d Analysis of
telomerase activity in H9 cells (passage 31+21). Telomerase activity
of H9 cells at passage 31 before the onset of experiments (lane 1) and
colonies maintained on hffECM for 21 additional passages with
conditioned media (lane 2) or on foreskin fibroblasts (lane 3). e
Quantitative PCR analysis of pluripotent gene expression in H9 cultures
maintained for 21 passages on hffECM or foreskin fibroblasts
176 Stem Cell Rev and Rep (2012) 8:170–183(Fig. 6a) changed continuously their trajectory and direction
as they moved around the center of the well. In contrast, the
cells maintained on either Matrigel or hffECM migrated
longer distances inside the well. Additionally, the movement
of cells on these supports was less haphazard and direction
changes were reduced drastically. Regarding the speed of
migration, cells grown on hffECM moved significantly faster
while no differences were observed between Matrigel and
plastic (Fig. 6b). Representative migration patterns of the
U87 cells cultured on the various supports can be viewed in
the videos 1–3 of Supplementary Information.
Discussion
The development of a standardized, animal-free culture
matrix is an essential tool for both elucidating the
mechanisms that control human stem cell biology and for
facilitating their application to cell-based clinical therapies
[32]. Here we report an efficient method for the obtention
and preservation of a functional ECM from human foreskin
fibroblasts. Our method has several key advantages over
other strategies for obtaining ECM. First of all, it is a
simple, low-cost biochemical method based on hypotonic
lysis that can be reproduced easily in cell biology labs.
Additionally, in contrast to previous chemical procedures
that disrupt some of the ECM protein structures [29, 33],
the hypotonic shock used in our method preserves the
architecture and bioactivity of the ECM scaffold. Indeed,
our hffECM was capable of maintaining hESC in the
undifferentiated state without inducing chromosomal aber-
rations during a significant amount of time (21 passages).
One observation regarding the hffECM that we initially
interpreted as a limitation was the slight reduction in the
number of colonies when hESC were continuously pas-
saged on hffECM as compared with those grown on HFF.
Fig. 5 Evaluation of hffECM as a support for directed differentiation
of hESC. Phase contrast images of hESC plated on hffECM and
subjected to a chemically-defined method for differentiation to
adipocytes. a 12 days in differentiation media, b Oil red O staining
of H9 cultures on day 11 of differentiation protocol. Scale bars:
100 μm, c Transmission electron microscopy characterization of
adipocytes obtained from H9 after 15 days of the differentiation
protocol. The cells display small nuclei, with sparse organelles and
large lipid droplets distributed along the cytoplasm. Scale bar: 5 μm. d
Analysis of adipocyte differentiation markers using RT-PCR. At the
indicated time points, mRNA was prepared for analysis by PCR.
Products were visualized by gel electrophoresis. The expression of
aP2 and PPAR gamma was quantified and normalized to 18 s mRNA
Stem Cell Rev and Rep (2012) 8:170–183 177However, when we analysed markers of pluripotency, the
expression of certain pluripotent genes such as Nanog and
FoxD3 was enhanced in the colonies maintained on
hffECM relative to the colonies on HFF, suggesting that,
although the attachment of hESC may be lower on hffECM
than on feeders, cells display a higher grade of pluripotency
when grown on this support.
Proteomic studies confirmed that the majority of proteins
which comprise the ECM [34, 35] were present in hffECM
after the decellularization induced by osmotic shock of
HFF, demonstrating that the procedure prevents enzymatic
degradation of the ECM. To date, proteomics has not been
applied to define the ECM required for the maintenance and
differentiation of hESC. The attachment and growth of all
types of cells is dependent on the interaction of integrins
expressed on the cell surface with the ECM. The subset of
integrins expressed in undifferentiated hESC is modified
during differentiation, implicating an important role for
integrins in maintaining pluripotency and growth [36]. Our
proteomics data reveal that the majority of the ECM
partners which interact with integrins are retained in the
hffECM (Fig. 3b), providing at least one molecular
explanation for the capacity of this matrix to support
growth and pluripotency of hESC during an extended
period of time (21 passages). Recent studies have demon-
strated that both integrin signaling and E-Cadherin signal-
ing are required for the survival and proliferation of hESC
[13]; enzymatic dissociation of hESC colonies induces
apoptosis by disrupting these critical cell-ECM interactions.
Collectively, our results demonstrate that hffECM retains
the composition and integrity of ECM molecules which
modulate self-renewal and survival of hESC. Thus, the use
of mass spectrometry techniques to precisely define the
protein composition of the hffECM may enable the
synthesis of a functional support on a large-scale and
provides basic information to tailor the composition to
particular cell types.
When hESC on hffECM were subjected to differenti-
ation using chemically-defined conditions, we observed
satisfactory results. Using an established protocol [27],
the efficiency of differentiation to adipocytes was compa-
rable to colonies maintained initially on feeder layers.
Combinations of growth factors and ECM can mimic in
vitro the cell-cell interactions that occur during develop-
ment, but data concerning the functional or spatial
similarities with real embryo development are lacking
[15]. Thus, hffECM provides an excellent opportunity to
differentiate hESC towards the three embryonic germ
Fig. 6 Analysis of random migration of human tumour cells on
hffECM, Matrigel and plastic. a Plots representing the different
trajectories followed by 20 randomly chosen cells growing on
hffECM, Matrigel and plastic. b Histogram depicting the average
speed of cells growing on the three different surfaces. * P<0.00007;
** P<0.0008
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basal lamina in vivo.
During embryo development or tumour progression, cells
usually migrate within a 3Dextracellular matrix environment.
The majority of in vitro assays have been performed using 2D
models. Computational studies have predicted that some
crucial migration parameters such as matrix stiffness and the
distribution of integrin forces at cell matrix-interface are
dramatically different in 2D versus 3D environment [37].
With the aim of extrapolating in vitro experiments to in vivo
processes, Zaman et al., 2006 [38]c o m p a r e dc e l lm i g r a t i o n
parameters in 2D [39] with Matrigel and observed clear
differences between these supports. When we compared the
migration of U87 cells on Matrigel versus hffECM as 3D
supports, we observed similar patterns, although the speed of
migration was superior on hffECM.
I ns u m m a r y ,w eh a v ed e v e l o p e das i m p l em e t h o dt h a t
generates a biologically active human ECM under
conditions which are compatible with clinical-grade
studies. Our hffECM supports the maintenance and
differentiation of hESC and based on our data, can be
applied to other types of stem cells which require a
physical support.
Materials and Methods
Culture and Maintenance of hESC
The present study was approved by the Commission for
Control of Transplants of the Carlos III Health Institute
and complies with the Spanish regulations for hESC
research. The human embryonic stem cell lines H9 and
H1 were purchased from Wicell (Wisconsin, USA) and
cultured as previously described [16]. H9 and H1
colonies were routinely passaged mechanically and
maintained on human foreskin fibroblasts (HFF) at 5%
CO2 and 37°C until the onset of the experiments
described below.
Culture of Human Fibroblasts and Preparation
of Conditioned Media
Human foreskin fibroblasts (ATCC Catalog No. CRL-2429,
Passage 11–18) were grown in Dulbecco’s modified Eagle
medium (DMEM) with high glucose, supplemented with
10% human serum (HS), 1% L-glutamine, and 1%
nonessential amino acid (NEAA). The HFF were split
using Triple Select every 5–7 days (all the above reagents
are from GIBCO, Invitrogen). When the cells reached
confluence, they were inactivated by 10μg/ml Mitomycin C
(Fluka, Catalog No. 69824) for 3 h, then washed three
times with PBS, digested, and 6×10
6 cells were seeded in
T75 flask coated with 0.1% gelatin (Sigma, Catalog No.
G1890). To generate conditioned media, cells were cultured
at 37°C, 5% CO2 in one of the following: Medium 1 or
TESR medium. Medium 1 contained 80% Knockout-
Dulbecco’s modified Eagle’s medium (KO-DMEM), 20%
KNOCKOUT serum replacement (Knockout SR), 1%
L-glutamine, 1% NEAA, 100μM 2-Mercaptoethanol (Sig-
ma, Catalog No.M7522). Medium was collected daily
during 1 week of culture. Before use as the culture medium
for hESC, 4 ng/ml human basic fibroblast growth factor
(bFGF) (Invitrogen, Catalog 13256–029) was added.
Conditioned medium was stored at −80°C for up to
6 months with no loss of biological activity.
Preparation of ECM from HFF(hffECM)
Extracellular matrix was prepared by buffer extraction of
human foreskin fibroblasts, using methods described by
Cukierman et al. 2001 [40] and Hedman et al. 1979 [41]
with some modifications. HFF cultures were washed twice
with PBS and treated with lysis buffer (10 mM Tris, 1 mM
EDTA, pH 7.4) using 1.5 ml per 10
6 cells. The cells were
incubated overnight at 4°C on an orbital shaker. Lysed cells
were eliminated from the plates by washing six times with
PBS. Plates were stored at 4°C or dried and sterilized using
standard methods.
Elution of hffECM
After preparation of the hffECM as described above,
culture plates were treated with 10 mM DTT in 5 M
sodium guanidine for 1 h at 4°C. The solubilized matrix
was collected by scraping the culture plates, followed by
three washes with the solubilization buffer. Samples were
then centrifuged for 20 min at high speed to concentrate the
eluted protein. Using these conditions, laminin was not
detected in the initial proteomic analysis. However, laminin
was noted as a component of the hffECM by IHC
performed on culture plates (Fig. 2). Thus, we used the
extraction protocol described by Kleinman et al. [42] with
slight modifications because it preserves the native struc-
ture of the protein. Culture plates were incubated in 3.4 M
NaCl buffer for 1 h at room temperature. Eluted samples
were then centrifuged 5 min at 8000×g at 4°C. The
supernatants were discarded and after the addition of
0.5 M NaCl buffer to the pellets, they were solubilized
overnight at 4°C. Subsequently, the homogenate was
centrifuged 15 min at 8000 × g at 4°C. The resulting
supernatant was collected on ice and ammonium sulfate
was added to 30% saturation (16.4 g/100 ml) with vigorous
stirring. Finally, these samples were centrifuged 15 min at
8000 × g at 4°C and the pellet was recovered and
resuspended [42].
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The hffECM samples were analyzed in two different ways.
Samples from both protocols were digested in solution with
sequencing grade trypsin (Promega) following the protocol
described by Shevchenko et al. [43]. In addition, the ECM
sample obtained by the second extraction procedure was
analyzed by SDS/PAGE using Bio-Rad Mini-PROTEAN
TGX precast gels with a 4–15% resolving gel. The gel lane
was cut into pieces, digested [44], and analyzed separately.
The digestion mixture was dried in a vacuum centrifuge,
resuspended in 6 μL of 0.1% TFA, and 5 μL were delivered
to a trap column (LC Packings Amsterdam, The Nether-
lands, C18 PepMap100, 5 μm, 300 μm×5 mm) using a
capillary HPLC (Switchos, LC Packings) via an isocratic
flow of mobile phase (0.1% trifluoroacetic acid in water) at
a flow rate of 30 μL/min for 3 min. The flow rate was the
switched to 200 nL/min, and the peptides were flushed onto
the analytical column (LC Packings C18 PepMap100, 3 μ
100Å, 75 μm×15 cm) and eluted via a mobile phase linear
gradient: 15–50% B (A: 0.1% formic acid in water, B: 0.1%
formic acid in 95% acetonitrile) over 150 min. The eluted
peptides were directly infused in a QSTAR XL mass
spectrometer (Applied Biosystems). The nanoESI QTOF
hybrid system was operated in information–dependent
acquisition mode, in which a 1-s TOF MS scan from 400
to 2000 m/z, was performed, followed by 1-s product ion
scans from 100 to 2000 m/z on the three most intense
doubly or triply charged ions. The MS/MS information
was sent to MASCOT v 2.2. using the MASCOT
DAEMON software v 2.2.2.
Protein Database Search and Functional Annotation
Peak list generation was performed with Mascot Daemon
2.2.2 (Matrix Science, Inc., Massachusetts, USA) using
Mascot.dll 1.6b25 or with ProteinPilot 3.0 (ABSCIEX)
using ABSciex. DataAccess.Wiff File DataReader.dll.
Mascot 2.2 and ProteinPilot 3.0 were used to search
Uniprot and NCBInr databases. Mascot search parameters
set trypsin cleavage specificity, allowing one mis-cleavage,
with mass tolerances of 100 ppm and 0.6 Da for MS and
MS/MS modes, respectively. Cysteine carbamidomethyla-
tionas fixed modification and methionine oxidation aswell as
glutamine and asparagine deamidation as variable modifica-
tions were specified. The taxonomy was set to Homo sapiens.
The Paragon algorithm used by ProteinPilot does not require
the manual setting of any of these parameters.
Functional annotation was performed with the FatiGO+
moduleofBabelomicstoexploreenrichmentofgeneontology
terms(GO)andKEGGpathwayswithintheidentifiedproteins
[25, 26]. The significant level was set to a p-value of 0.01.
We focused on the Cellular Compartment terms of GO in
order to evaluate the precedence of the identified proteins.
Interactions among the proteins belonging to the significantly
enriched cellular components were analyzed with STRING.
Clustering of the networks was done using the MCL
algorithm with the parameter “inflation” set to 2.
Ultrastructural Study of hffECM Organization
and Thickness
For ultrastructural analysis of ECM organization, ECM
coated plates as well as the corresponding controls
containing feeder cells, were repeatedly washed in a
0,1 M phosphate buffer (PB; pH 7.4) solution, before
fixation for Transmission Electron Microscopy (TEM).
Fixation was performed in 3% glutaraldehyde solution in
PB for 30 min at 37°C and postfixed in 2% OsO4 in
PBS. Samples were stained with 2% uranyl acetate
(Electron Mycroscopy Science, Washington). Dehydration
was achieved by a graded series of ethanol and samples
were embedded in propylene oxide (Lab Baker, Deventry,
Holland). Finally, plates were incubated with araldite
(Durkupan, Fluka) overnight.Following polymerization,
embedded samples were detached from the chamber
slide and glued to Araldite blocks. Serial semi-thin
(1.5 μm) sections were cut with an Ultracut UC-6 (Leica,
Heidelberg, Germany) and mounted onto slides and
stained with 1% toluidine blue. Selected semi-thin
sections were glued (Super Glue, Loctite) to araldite
blocks and detached from the glass slide by repeated
freezing (in liquid nitrogen) and thawing. Ultrathin
(0.07 μm) sections were prepared with the Ultracut and
stained with lead citrate. Finally, photomicrographs
were obtained under a transmission electron micro-
scope (FEI Tecnai Spirit G2) using a digital camera
(Morada, Soft Imaging System, Olympus).
For immunocytochemistry, the plates containing hffECM
were fixed in 2% paraformaldehyde and washed three
times with PBS before staining o.n. with mouse anti-
human fibronectin (1:250 Sigma), rabbit anti-human
collagen type I (1:400 Millipore), mouse anti-human
laminin (1:500 Sigma). Non-specific binding was
blocked with normal goat serum in PBS. For secondary
detection depending on the primary, goat anti-mouse Alexa
488 and goat anti-rabbit Alexa 647 were used (1:500
Millipore). Following incubation with secondary antibodies,
cells were washed four times with PBS and mounted using
Prolong Gold AntiFade Reagent with Dapi (Invitrogen).
Images were obtained using the Leica SP2 confocal.
Analysis of Pluripotency
For immunocytochemistry, culture media was removed
from the hESC and cells were washed carefully with
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hyde. Subsequently, cells were washed three times with
PBS and permeabilized with 0.5% Triton X-100
(Sigma- Aldrich) at room temperature. Non-specific
binding was blocked with normal goat serum in PBS.
Primary antibodies (SSEA-3/4, SSEA-1, TRA- 1–60,
TRA-1- 81) of the ES Cell Characterization
Kit (1:50 Millipore) were diluted according to the
manufacturer’s instructions and incubated overnight at
4°C. For detection with secondary antibodies, IgG1
Alexa488 was used for SSEA-4, and IgM Alexa488 for
T r a 1 - 6 0a n dT r a 1 - 8 0 .A f t e r1ho fi n c u b a t i o na tr o o m
temperature, samples were washed four times with PBS
and mounted using Prolong Gold Anti-Fade Reagent
with Dapi (Invitrogen). Images were obtained at a 10X
magnification using the Zeiss Axiovert 200 M.
Chromosomal Analysis
Cytogenetic analysis was conducted at passages 17 and 21
after transfer of hESC colonies to hffECM-coated plates.
Dividing cells were arrested at metaphase by the addition of
50 μg/ml of colchicine for 2 h and then harvested using
standard cytogenetic techniques. Harvested metaphase
chromosomes were stained. Giemsa/Trypsin/Leishman
(GTL) banding techniques were employed for karyotype
analysis. An average of 30 banded metaphase spreads were
karyotyped and analyzed for chromosomal rearrangements.
GTL- banded metaphase spreads were captured and
arranged using Cytovision software from Applied Imaging
(Santa Carla, CA, USA).
RNA Preparation and RT-PCR
Total RNA was prepared from cells using RNeasy mini kit
(Quiagen, Gilden; no. 74104). To eliminate contaminating
genomic DNA, the initial RNA pellet was incubated with
deoxyribonuclease (DNase) I (2 to 4 U/μL; Qiagen,
Carlsbad; no.79254) for 15 min at room temperature in
the buffer supplied by the manufacturer. RT–PCR and
primer sequences were as described in the Supplemental
Table S2. They were designed using Primer3 software and
synthesized by Sigma–Aldrich. For each experiment,
controls were performed in which reverse transcriptase
was omitted from the cDNA reaction mixture and template
DNA was omitted from the PCR mixture. For quantitative
real-time PCR (QRT-PCR), 5 μg RNA was converted into
cDNA, and a series of diluted samples were used for
40-cycle PCR in Light Cycler 480 SYBR Green I Master
(Kit no. 04707516001) in an Lightcycler 480 (Roche
Diagnostics,Mannheim) instrument. Reactions (20 μL total)
contained 1 μL cDNA, 10 μM each primer, and 4 μM
probe and were run using the default Lightcycler 480
program. To generate a standard curve for comparison of
mRNA levels in different samples, multiple dilutions of the
control cDNA sample, spanning at least 3 orders of
magnitude, were prepared. The equation describing the
plot of threshold cycle, Ct, versus log concentration was
used to determine relative amounts of mRNA in experi-
mental samples. Using the optimized conditions and
threshold values, individual samples were analyzed in
triplicate using the probe of interest and an internal control
expected to be unchanged between samples. Three different
internal controls were used: glyceraldehyde-3-phosphate-
dehydrogenase (Gapdh), β-2 microglobulin, and β-actin.
From the Ct values, the relative transcript concentration was
calculated and normalized to that of the internal control.
The maximum expression data point was adjusted to 100.
Data are shown for samples normalized to Gapdh, but
results were comparable when analysis was performed
using either β-2 microglobulin alone or a combination of all
3 controls.
Telomerase Activity Assay
Telomerase activity was assayed by telomere repeat
amplification protocol using Trapeze Kit (Chemicon) and
according to the manufacturer’s protocol.
Analysis of hESC Differentiation
Spontaneous in vitro differentiation was evaluated by
allowing hESC to overgrow on hffECM in growth media
without basic fibroblast growth factor bFGF (Invitrogen). To
induce adipocyte differentiation, the hESC were seeded in
triplicateonECM-coatedwellsofa6-wellplateatadensityof
around 30 hESC colonies/well (about 300–500 cells per
colony) in CM. Cultures were then maintained continuously
in Differentiation medium 1 (DM1): 80% Knock-out Dulbec-
co’sm o d i f i e dE a g l e ’s medium DMEM/F12, 20% Knock-out
serum replacement, 1 mmol/L L-glutamine, 100 μM
2-Mercaptoethanol, 1% MEM non-essential amino acids.
The medium was changed every other day. Culture samples
were collected atday 0, day 3,day 6, day 9, day12, and day15
and analyzed by Oil Red O staining and RT-PCR.
Analysis of Cell Migration
The human brain tumour cell line U-87 MG was grown
in Ham’s F-12 supplemented with 10% FBS. For the
assay, 5×10
3 per well were seeded onto three replicate
96-well plates coated with Matrigel, hffECM or plastic
respectively, and maintained for at least 3 h in a incubator
before the experiment. During the migration experiment
(8 h), plates were placed in a pre-equilibrated In-Cell
Analyzer 1000 Chamber and imaged every 10 min using
Stem Cell Rev and Rep (2012) 8:170–183 18110X objective with 2000 exposure. Images were analyzed
with In-Cell Investigator software using the cell tracking
analysis tool to create plots of X-Y position and time
variables. The particles with the same identification
number were connected by a line representing the
continuous track for a cell (GE Healthcare application
Note 28-9327-11 AA). For statistical comparison of the
parametric data obtained, we used the t-test analysis of
variance for two groups.
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